Lifeboat Foundation

The number of deaths linked to a Listeria outbreak from meat products in 2019 has doubled.

It had been thought 21 people were infected with Listeria monocytogenes in the Netherlands and Belgium. One person fell sick in October 2017, eight in 2018, and 12 in 2019. Three people died. All patients were hospitalized and one woman had a miscarriage. Two Dutch patients were pregnant women in their 30s. The others were from 64 to 94 years old and 10 were men.

Now it is known that Listeria in processed meats from Offerman, a Ter Beke subsidiary, made 35 people sick. Two women miscarried and six patients died. The information was revealed in the Dutch Food and Consumer Product Safety Authority’s (NVWA) annual report.

NASA has released a stunning image taken by the NASA/ESA Hubble Space Telescope of the edge-on spiral galaxy NGC 5907.

To create artificial general intelligence, we need to study the brain.

Relativity Space, a growing startup that aims to almost entirely 3D-print rockets, on Wednesday announced it struck another major launch deal, as well as an agreement with the U.S. Air Force, to build a launchpad on the California coastline.

The Los Angeles-based rocket builder signed an agreement with satellite operator Iridium Communications, to launch up to six satellites as needed as early as 2023. Over the course of more than half a dozen launches with SpaceX, Iridium completed its second-generation satellite constellation in January 2019, with 66 operational satellites and 9 spares in orbit.

The Iridium deal means Relativity now has agreements to launch for five different companies, having previously announced contracts with Canadian satellite communications operator Telesat, California-based Momentus, Thai satellite broadband company mu Space and Seattle-based Spaceflight Inc. All the contracts have remarkably come before Relativity’s first launch, which is scheduled to happen before the end of 2021.

The world’s largest genetic study into chronic fatigue syndrome is to be launched in the UK after receiving £3.2m of funding from the Medical Research Council and National Institute for Health Research.

The research aims to shine a light on the debilitating long-term condition, about which little is known, by collecting DNA samples from 20,000 people who have CFS, also known as myalgic encephalomyelitis (ME).

CFS is believed to affect about 250,000 people in the UK and has been estimated to cost the economy billions of pounds each year. Individuals experience exhaustion that is not helped by rest, with one in four so severely affected they are unable to leave the house and, frequently, unable to leave their bed. Other symptoms include, pain, mental fogginess, light and noise sensitivities, as well as trouble with memory and sleep. No effective treatment exists.

The governing council of the European Organization for Nuclear Research, known internationally as CERN, wants to build a brand new, bigger-than-ever $23.6 billion particle collider. At one time, CERN’s Large Hadron Collider (LHC) made news for costing a mere $5 billion. Is the escalating cost of these colliders worth it for the research scientists are able to do?

At least one prominent physicist says no. Sabine Hossenfelder, a theoretical physicist at the Frankfurt Institute for Advanced Studies, argues in Scientific American that bigger and bigger particle collider schemes have run out of room to make meaningful progress.

Springer ditches paper from research tome, boffins rail against junk science.

Dust is on the way to the United States this week making the more than 6,000-mile journey from the Sahara Desert.

This might seem to work against typical weather patterns, but dust in the United States from the Sahara happens every year. While it may not be abnormal to see the Saharan dust make its annual journey to the United States, we are expected to see more of it than usual.

Tiny individual dust particles combine to make a large plume so big that it can be picked up on satellite images and even be seen from the International Space Station.

New research untangles the complex code the brain uses to distinguish between a vast array of smells, offering a scientific explanation for how it separates baby powder from bleach, lemon from orange, or freshly cut grass from freshly brewed coffee.

A single scent can trigger a complex chain of events in what’s known as the olfactory bulb, the brain’s control center for smell. To unravel the intricacies of that process, researchers in the U.S. and Italy turned to a technique known as optogenetics, which uses light to control neurons in the brain. In research on mice, they used light to trick the brain into thinking it smelled a particular scent, then studied brain activity to understand the role different neurons play in a mouse’s ability to recognize that scent. Their findings were published Thursday in Science.

When we encounter a certain smell, it stimulates a specific pattern of activity among tiny spheres known as glomeruli, which are found in the olfactory bulb. The odor plays across these glomeruli like a melody across piano keys: Just as a tune is made distinct by which keys are pressed and at what point in the melody, a scent is made distinct by which glomeruli are activated and in what order.